IMMUNE AND CYTOKINE STATUS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING ALEMTUZUMAB

In present work, we studied cytokine levels and performed analysis of some immunologic parameters in the patients with chronic lymphocytic leukemia (CLL) before and after treatment with monoclonal anti-CD52 antibody (alemtuzumab). In comparison with a control group, the CLL patients before alemtuzum...

Full description

Saved in:
Bibliographic Details
Main Authors: M. N Khorobrykh, T. P. Zagoskina, V. I. Shardakov, E. L. Nazarova, A. V. Yovdiy
Format: Artigo
Language:Russo
Published: SPb RAACI 2014-07-01
Series:Medicinskaâ Immunologiâ
Subjects:
chronic lymphocytic leukemia
cytokines
lymphocyte subsets
alemtuzumab
cd52
Online Access:https://www.mimmun.ru/mimmun/article/view/408
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items